Mandel Center for Heart and Vascular Research, The Cardiovascular Research Center, Duke University Medical Center, Durham, NC 27710, United States.
Mandel Center for Heart and Vascular Research, The Cardiovascular Research Center, Duke University Medical Center, Durham, NC 27710, United States; Deparment of Medicine, Clinical Pharmacology Division, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
J Mol Cell Cardiol. 2018 Oct;123:64-74. doi: 10.1016/j.yjmcc.2018.08.024. Epub 2018 Aug 29.
There is much interest over resident c-Kit(+) cells in tissue regeneration. Their role in cardiac regeneration has been controversial. In this study we aim to understand the in vivo behavior of cardiac c-Kit(+) cells at baseline and after myocardial infarction and in response to Sfrp2. This approach can accurately study the in vivo transcript expressions of these cells in temporal response to injury and overcomes the limitations of the in vitro approach. RNA-seq was performed with c-Kit(+) cells and cardiomyocytes from healthy non-injured mice as well as c-Kit(+) cells from 1 day post-MI and 12 days post-MI mice. When compared to in vivo c-Kit(+) cells isolated from a healthy non-injured mouse heart, cardiomyocytes were enriched in transcripts that express anion channels, cation channels, developmental/differentiation pathway components, as well as proteins that inhibit canonical Wnt/β-catenin signaling. Myocardial infarction (MI) induced in vivo c-Kit(+) cells to transiently adopt the cardiomyocyte-specific signature: expression of a number of cardiomyocyte-specific transcripts was maximal 1 day post-MI and declined by 12 days post-MI. We next studied the effect of β-catenin inhibition on in vivo c-Kit(+) cells by administering the Wnt inhibitor Sfrp2 into the infarct border zone. Sfrp2 both enhanced and sustained cardiomyocyte-specific gene expression in the in vivo c-Kit(+) cells: expression of cardiomyocyte-specific transcripts was higher and there was no decline in expression by 12 days post-MI. Further analysis of the biology of c-Kit(+) cells identified that culture induced a significant and irreversible change in their molecular signature raising questions about reliability of in vitro studies. Our findings provide evidence that MI induces in vivo c-Kit(+) cells to adopt transiently a cardiomyocyte-specific pattern of gene expression, and Sfrp2 further enhances and induces sustained gene expression. Our approach is important for understanding c-Kit(+) cells in cardiac regeneration and also has broad implications in the investigation of in vivo resident stem cells in other areas of tissue regeneration.
人们对组织再生中的驻留 c-Kit(+)细胞非常感兴趣。它们在心脏再生中的作用一直存在争议。在这项研究中,我们旨在了解心脏 c-Kit(+)细胞在基线和心肌梗死后的体内行为,以及对 Sfrp2 的反应。这种方法可以准确地研究这些细胞在受到损伤时的体内转录表达,并克服了体外方法的局限性。我们对来自健康非损伤小鼠的 c-Kit(+)细胞和心肌细胞以及来自心肌梗死后 1 天和 12 天的小鼠的 c-Kit(+)细胞进行了 RNA-seq 分析。与从健康非损伤小鼠心脏中分离的体内 c-Kit(+)细胞相比,心肌细胞中富含表达阴离子通道、阳离子通道、发育/分化途径成分以及抑制经典 Wnt/β-catenin 信号的蛋白质的转录本。心肌梗死 (MI) 使体内 c-Kit(+)细胞短暂地采用心肌细胞特异性特征:许多心肌细胞特异性转录本的表达在 MI 后 1 天达到最大值,并在 MI 后 12 天下降。我们接下来通过在梗死边界区给予 Wnt 抑制剂 Sfrp2 来研究β-catenin 抑制对体内 c-Kit(+)细胞的影响。Sfrp2 增强并维持体内 c-Kit(+)细胞中的心肌细胞特异性基因表达:心肌细胞特异性转录本的表达更高,到 MI 后 12 天没有表达下降。对 c-Kit(+)细胞生物学的进一步分析表明,培养对其分子特征产生了显著且不可逆的变化,这引发了对体外研究可靠性的质疑。我们的研究结果表明,MI 诱导体内 c-Kit(+)细胞短暂地采用心肌细胞特异性基因表达模式,而 Sfrp2 进一步增强并诱导持续的基因表达。我们的方法对于理解心脏再生中的 c-Kit(+)细胞非常重要,并且对其他组织再生领域中体内驻留干细胞的研究也具有广泛的意义。